Muscular Dystrophy

Overview of Duchenne, Becker, and other muscular dystrophies.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
NeurologyGenetics

Clinical Guidelines

NICE guidance [HST22]: Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation
National
NICE guidance [TA1031]: Vamorolone for treating Duchenne muscular dystrophy
National
NICE guidance [TA755]: Risdiplam for treating spinal muscular atrophy
National
NICE guideline [HST22]: Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation
National
NICE guideline [TA1031]: Vamorolone for treating Duchenne muscular dystrophy
National
NICE guideline [TA755]: Risdiplam for treating spinal muscular atrophy
National
2022 HRS expert consensus statement on evaluation and management of arrhythmias in neuromuscular disorders
Local
Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy (FSHD)
Local
Care Guidelines for Duchenne Muscular Dystrophy (Parent Project Muscular Dystrophy)
Local
Clinical investigation of medicinal products for the treatment of Duchenne and Becker muscular dystrophy: Scientific guideline
Local
Consensus Guidelines for Safe and Equitable Delivery of Gene Therapy in Duchenne Muscular Dystrophy (MDA and PPMD)
Local
Consensus Statement on Standard of Care for Congenital Muscular Dystrophies
Local
Development of respiratory care guidelines for Duchenne muscular dystrophy in the UK: key recommendations for clinical practice
Local
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Local
Duchenne Muscular Dystrophy and Related Dystrophinopathies: Developing Drugs for Treatment Guidance for Industry
Local
Management of Cardiac Involvement Associated With Muscular Dystrophies: A Scientific Statement From the American Heart Association
Local
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology
Local
Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement
Local